CredoScientia - Bibliothèque

Oncological Outcomes Following Different TACE-Based Conversion Therapies for Intermediate-Advanced Hepatocellular Carcinoma.

BACKGROUND: Transcatheter arterial chemoembolization (TACE) is widely used for intermediate-advanced hepatocellular carcinoma (HCC). The efficacy and safety of TACE combined with systemic treatments a…

Thérapies de Conversion

Xu, H., Liu, Y., Zhang, H., Wu, H., Li, B., Chen, K., & Wei, Y. (2026). Oncological Outcomes Following Different TACE-Based Conversion Therapies for Intermediate-Advanced Hepatocellular Carcinoma.. Cancer Med, 15(4), e71867. https://doi.org/10.1002/cam4.71867

01/04/2026 Lire →

Surgery-centered integrated strategies for personalized hepatocellular carcinoma care.

Hepatocellular carcinoma (HCC) remains a major global health burden characterized by late-stage diagnosis and high postoperative recurrence rates. This review presents a surgery-centered precision man…

Thérapies de Conversion

Cui, Y., Du, Z., Xu, J., Gu, L., Du, J., Wang, M., & Yang, T. (2026). Surgery-centered integrated strategies for personalized hepatocellular carcinoma care.. Cancer Biol Med. https://doi.org/10.20892/j.issn.2095-3941.2026.0045

30/03/2026 Lire →

Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment.

BACKGROUND/AIMS: Most patients with intrahepatic cholangiocarcinoma (ICC) present with advanced, unresectable disease. Although gemcitabine-cisplatin (GC) plus durvalumab improves outcomes, its real-w…

Thérapies de Conversion

Xu, J., Ji, Y., Feng, M., Zhang, Z., & Yu, D. (2026). Gemcitabine-cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma: effectiveness outcomes and characterization of the tumor microenvironment.. Hepatol Int. https://doi.org/10.1007/s12072-026-11070-y

24/03/2026 Lire →

Efficacy and Safety of Conversion Surgery Versus Non-Surgical Treatment for Initially Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.

Thérapies de Conversion

Chen, L., Zhao, J., & Luo, X. (2026). Efficacy and Safety of Conversion Surgery Versus Non-Surgical Treatment for Initially Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.. J Gastrointest Cancer, 57(1). https://doi.org/10.1007/s12029-026-01440-y

23/03/2026 Lire →

[Recent advances in hepatic arterial infusion chemotherapy for conversion therapy of hepatocellular carcinoma].

Hepatocellular carcinoma(HCC) is one of the common malignant tumors in China. Most patients are diagnosed at an intermediate or advanced stage, thereby losing the opportunity for curative treatment. T…

Thérapies de Conversion

Chen, M. S., & Xiao, R. (2026). [Recent advances in hepatic arterial infusion chemotherapy for conversion therapy of hepatocellular carcinoma].. Zhonghua Yi Xue Za Zhi, 106(10), 891-896. https://doi.org/10.3760/cma.j.cn112137-20251021-02699

17/03/2026 Lire →

[Sequential surgery following conversion therapy based on the combination of immune checkpoint inhibitors and antiangiogenic targeted drugs alters the treatment landscape and outcomes for advanced hepatocellular carcinoma].

Hepatocellular carcinoma (HCC) often presents insidiously, and the majority of patients are diagnosed at an advanced stage, missing the opportunity for curative surgery. In recent years, breakthrough …

Thérapies de Conversion

Tang, H. W., Jiang, H. X., Cao, Y. B., & Lu, S. C. (2026). [Sequential surgery following conversion therapy based on the combination of immune checkpoint inhibitors and antiangiogenic targeted drugs alters the treatment landscape and outcomes for advanced hepatocellular carcinoma].. Zhonghua Yi Xue Za Zhi, 106(10), 885-890. https://doi.org/10.3760/cma.j.cn112137-20251116-02982

17/03/2026 Lire →

LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being: A Prospective, Naturalistic Study.

Sexual and gender minority (SGM) individuals experience disproportionately high rates of depression, anxiety, trauma, and discrimination, yet remain underrepresented in psychedelic research. This pros…

Spiritualité Saine et Résilience Thérapies de Conversion

Lowe, M. X., Darby, Q. A., Kalcheff-Korn, S., & Jackson, H. (2026). LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being: A Prospective, Naturalistic Study.. J Psychoactive Drugs, 1-12. https://doi.org/10.1080/02791072.2026.2644858

13/03/2026 Lire →

Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.

BACKGROUND: The management of initially unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) has been revolutionized by conversion therapy combining locoregional and syst…

Thérapies de Conversion

Wang, L., Feng, J. K., Zhou, B., Liu, Z. H., Gong, L., Yan, M. L., Zhao, H. T., Jiang, Y. B., Shi, J., Guo, W. X., Yuan, Y., Lu, C. D., & Cheng, S. Q. (2026). Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.. Oncologist, 31(4). https://doi.org/10.1093/oncolo/oyag054

09/03/2026 Lire →

Expert consensus on the use of immune checkpoint inhibitors in the liver transplant setting: Guidance from the Liver Transplant Committee of the Italian Association for the Study of the Liver (AISF).

Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for advanced hepatocellular carcinoma, increasing opportunities for downstaging and conversion to liver transplantation (LT…

Thérapies de Conversion

Ponziani, F. R., Giannelli, V., Marrone, G., Martini, S., Morelli, M. C., Pagano, D., Baroni, G. S., Germani, G., Burra, P., & Toniutto, P. (2026). Expert consensus on the use of immune checkpoint inhibitors in the liver transplant setting: Guidance from the Liver Transplant Committee of the Italian Association for the Study of the Liver (AISF).. Am J Transplant. https://doi.org/10.1016/j.ajt.2026.02.024

03/03/2026 Lire →

Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy.

Yttrium-90 microsphere selective internal radiation therapy (SIRT), also known as transarterial radioembolization, has become one of the pivotal treatments for liver cancer, particularly for selected …

Thérapies de Conversion

Liang, L., Liang, Y., Huang, W., Guo, Y., Huang, J., Zhou, J., Lin, L., Nie, X., Cai, M., & Zhu, K. (2026). Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy.. Liver Res, 10(1), 61-70. https://doi.org/10.1016/j.livres.2025.12.002

01/03/2026 Lire →

Advancing hepatology through innovation and integration: 's vision for 2026.

Thérapies de Conversion

Du, Z. C., Wang, K. C., Wang, M. D., Cai, L., Zhong, J. H., & Yang, T. (2026). Advancing hepatology through innovation and integration: 's vision for 2026.. ILIVER, 5(1), 100224. https://doi.org/10.1016/j.iliver.2026.100224

01/03/2026 Lire →

Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review.

Conversion therapy, defined as curative-intent surgery or chemoradiotherapy after induction therapy, is gaining attention in patients with initially unresectable esophageal squamous cell carcinoma due…

Thérapies de Conversion

Booka, E., & Takeuchi, H. (2026). Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review.. Ann Gastroenterol Surg, 10(2), 294-304. https://doi.org/10.1002/ags3.70104

01/03/2026 Lire →